United States — Maine Act or statute

United States — Maine legislation

Maine Revised Statutes, Title 32, § 13815: Authorization, 2015

The board must set rules for authorizing pharmacists to prescribe and dispense naloxone or another FDA-approved opioid overdose-reversing medication, and it must require training and protocols when no prescription order,…

naloxone dispensingpharmacist authorizationprescription protocols

Professional statute overview

Enactment structure, operative effect and source provenance

Official source

01

Purpose and legislative effect

“The board must set rules for authorizing pharmacists to prescribe and dispense naloxone or another FDA-approved opioid overdose-reversing medication, and it must require training and protocols when no prescription order, standing order, or collaborative practice agreement exists.”

Use this record to locate individual provisions, understand the instrument’s recorded structure, and move from a research summary to the exact source text.

02

How the instrument operates

  1. 01

    Start with the recorded version

    Enacted 2015 · Source version 1 Oct 2025. The date shown identifies this source expression and should not be treated as proof that no later change exists.

  2. 02

    Locate the controlling provision

    Use the provision map, part headings and full-text filter to move from the broad subject to the exact legal language.

  3. 03

    Read conditions and exceptions together

    Keep subsections, definitions, provisos and cross-references in context before drawing a legal conclusion.

  4. 04

    Verify currency and official wording

    Confirm later legislation, commencement notices and corrections with the official publisher before advice, filing or reliance.

03

Research entry points

Selected provisions across the instrument. Open any row to continue with the exact stored text.

Authorization

The board must set rules for authorizing pharmacists to prescribe and dispense naloxone or another FDA-approved opioid overdose-reversing medication, and it must require training and protocols when no prescription order, standing order, or collaborative…

Section 13815

04

Source and current-law status

Source record view

Source record from legislature.maine.gov · Enacted 2015 · Source version 1 Oct 2025

Verify current force

The source record does not state a definitive current-law status. Check the official publisher and later amendments before relying on this text.

Source-indexed provision map

Sections and provisions

Search by section, heading, part or exact legal wording. Every result remains linked to the stored source record.

Showing 1 of 1 provisions

Provision
§ 13815AuthorizationProvision

The board must set rules for authorizing pharmacists to prescribe and dispense naloxone or another FDA-approved opioid overdose-reversing medication, and it must require training and protocols when no prescription order, standing order, or collaborative practice agreement exists.

1. Rules for dispensing naloxone hydrochloride. [PL 2017, c. 364, §6 (RP).] 2. Rules for prescribing and dispensing naloxone hydrochloride or another opioid overdose-reversing medication. The board by rule shall establish standards for authorizing pharmacists to prescribe and dispense naloxone hydrochloride or another opioid overdose-reversing medication in accordance with Title 22, section 2353, subsection 2, paragraphs A‑1 and C‑1. The rules must establish adequate training requirements and protocols for prescribing and dispensing naloxone hydrochloride or another opioid overdose-reversing medication when there is no prescription drug order, standing order or collaborative practice agreement authorizing naloxone hydrochloride or another opioid overdose-reversing medication to be dispensed to the intended recipient. Rules adopted under this subsection are routine technical rules as defined in Title 5, chapter 375, subchapter 2‑A. A pharmacist authorized by the board pursuant to this subsection to prescribe and dispense naloxone hydrochloride or another opioid overdose-reversing medication may prescribe and dispense naloxone hydrochloride or another opioid overdose-reversing medication in accordance with Title 22, section 2353, subsection 2, paragraphs A‑1 and C‑1. An opioid overdose-reversing medication referenced in this subsection must be approved by the federal Food and Drug Administration. [PL 2023, c. 161, §8 (AMD).]
Section 13815Verify source

Legislative relationships

0 referenced instruments

Names are derived from the stored provision headings and citation-enrichment layer. Treat this as a research index and verify each relationship against the source text.

No structured legislative relationships were detected

The statute remains fully searchable by provision. Consult the source text for amendments and cross-references that have not yet been indexed.

Recorded versions and source checkpoint

1 version available in this collection

Current-law checkpoint
  • 1 Oct 2025 · currentEnglish

Source-linked research

Ask AI about this statute

The overview, provisions, and source records above are public. Continue in a separate conversation with this statute’s jurisdiction and source version attached.

No legal research model is currently available.

Sign in

About this LexChat collection

Statute information is organised from identified legislative sources for professional research. Corrections can be reported to hello@esheria.ai.